Northern Swan Holdings Appoints Representative Joe Crowley to Advisory Board
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Northern Swan Holdings, Inc. (“Northern Swan” or “the Company”), an investment and operating platform focused on transforming the international cannabis industry, announced today the appointment of Representative Joe Crowley to its Board of Advisors.
“As an active and vocal proponent of affordable healthcare in the U.S., we are confident Representative Crowley will add great value to our company’s strategy and help those in need gain access to high quality medical cannabis,” said Kyle Detwiler, CEO of Northern Swan. “Through his continued support of the Medical Marijuana Use Amendment, which started in 2005, he has been a key mover in Americans expressing their right to medicine. We look forward to having Representative Crowley also push these initiatives forward with us.”
“While the stigma of cannabis is on the decline, America still has a long way to go on that path. It is therefore imperative that we improve medical cannabis programs at both a state and federal level. I am confident that I can help Northern Swan navigate the regulatory system and provide medical cannabis to patients in need,” said Representative Joe Crowley.
For more than two decades, Representative Crowley served in the U.S House of Representatives, where he had the honor of serving the people of New York’s 14th Congressional District, which includes Crowley’s hometown of Woodside, Queens. During his time in Congress, Crowley spent six years serving in elected leadership, including two years as the Chairman of the Democratic Caucus - the fourth highest ranking position among House Democrats. Crowley was also a member of the Committee on Ways and Means.
To date, Northern Swan has raised approximately $100 million. These funds will be used to expand its existing Latin American operations, invest in new low-cost, large-scale cannabis cultivation and processing centers and build out distribution channels and brands in Europe, Latin America and North America. Northern Swan has invested in several companies spanning the global cannabis value chain including Clever Leaves, a leading vertically integrated licensed producer of medical cannabis in Colombia, Cansativa GmbH, a German cannabis distribution company, Lift & Co., a Canadian marketing and data company, and a national manufacturer and distributor of health and wellness products in Tempe, Arizona.
About Northern SwanNorthern Swan is an investment and operating platform focused on transforming the cannabis industry in geographies where it is federally legal. With offices in New York, Toronto, Bogota, and Frankfurt, Northern Swan invests in and assists emerging companies in developing low-cost production capacity and distribution capabilities to improve distribution globally and generate brand value. Prior to founding Northern Swan, its management team has collectively invested in excess of $3 billion of capital at Blackstone, KKR, and Och-Ziff.
Forward-Looking Information This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, the Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors.
Media Contact:Gretchen GaileyKCSA Strategic Communications +1 347-487-6186 email@example.com